Variations in compliance among hypertensive patients by drug class: implications for health care costs.

@article{Rizzo1997VariationsIC,
  title={Variations in compliance among hypertensive patients by drug class: implications for health care costs.},
  author={John A. Rizzo and W. Robert Simons},
  journal={Clinical therapeutics},
  year={1997},
  volume={19 6},
  pages={1446-57; discussion 1424-5}
}
Health care decision-makers require more information on differences in compliance rates associated with alternative classes of antihypertensive drugs and the implications of these differences for health care utilization and costs. We examined medical claims data from the Pennsylvania Medicaid Management Information System to investigate compliance rates for four major antihypertensive drug classes (angiotensin-converting enzyme [ACE] inhibitors, beta-blockers, calcium antagonists, and diuretics… CONTINUE READING